Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

92.93 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Marjorie Taylor Greene Hits Homerun Again, Buys Alphabet Stock 5 Days Before Favorable Antitrust Ruling: Here Are Some Other New Trades ↗

September 03, 2025

Rep. Marjorie Taylor Greene buys Google stock just days before a key antitrust ruling. See her latest trades and portfolio performance.

Via Benzinga

This Merck Pill Promises Powerful Cholesterol Reduction Without Injections ↗

September 02, 2025

Merck's Coralreef Lipids trial showed enlicitide cut LDL-C and other lipid markers, while pooled Verquvo data hinted at heart failure benefits.

Via Benzinga

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

September 02, 2025

Are the Dow's biggest yields a bargain or a warning sign? Here's how the top payouts stack up, and what that could mean for income investors.

Via The Motley Fool

Topics Stocks

Merck’s Investigational Drug Shows Reduction In Cholesterol In Late-stage Trial ↗

September 02, 2025

Via Stocktwits

CSX, Intel, Palantir, Nvidia, Merck: What Sparked Heavy After-Hours Trading In These 5 Stocks? ↗

August 20, 2025

Via Stocktwits

Merck’s Investigational Oral PCSK9 Inhibitor Enlicitide Decanoate Met All Primary and Key Secondary Endpoints in Adults with Hypercholesterolemia in Pivotal CORALreef Lipids Study

September 02, 2025

From Merck & Co., Inc.

Via Business Wire

Merck to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

September 02, 2025

From Merck & Co., Inc.

Via Business Wire

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Turn Down

September 01, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Bernie Sanders Demands Health Secretary RFK Jr.'s Resignation As CDC Leadership Crisis Deepens ↗

August 30, 2025

Senator Bernie Sanders called for HHS Secretary RFK Jr.'s resignation over his anti-vaccine policies, ousting of CDC Director Susan Monarez.

Via Benzinga

Merck & Co. Inc. (NYSE:MRK) Stands Out as a High-Quality Dividend Stock ↗

August 30, 2025

Discover Merck (MRK), a top dividend stock with a 3.76% yield, strong growth history, and excellent financial health for sustainable income.

Via Chartmill

Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction

August 30, 2025

From Merck & Co., Inc.

Via Business Wire

Elizabeth Warren Slams Trump's CDC Purge: Calls Out RFK Jr's Statements On Measles Vaccines — 'These Fools Can't Be Trusted With Your Health' ↗

August 29, 2025

Sen. Elizabeth Warren (D-Mass.) is sounding the alarm on President Donald Trump's attempts at overhauling leadership at the Centers for Disease Control and Prevention, warning of risks to public...

Via Benzinga

Topics Government

Merck to Participate in the 2025 Wells Fargo Healthcare Conference

August 28, 2025

From Merck & Co., Inc.

Via Business Wire

1 Safe-and-Steady Stock Worth Your Attention and 2 We Question

August 28, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

Topics Bonds

Summit, Akeso Report Lung Cancer Survival Boost With Ivonescimab, A Rival To Merck's Keytruda Multi-Billion Dollar Franchise, Says Analyst ↗

August 27, 2025

Summit and Akeso report ivonescimab's survival benefit in lung cancer, boosting approval odds and positioning it as a Keytruda challenger.

Via Benzinga

Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn

August 27, 2025

The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy...

Via MarketMinute

Topics Artificial Intelligence Economy Emissions

EU Rushes To Scrap Tariffs On US Goods To Unlock Lower American Auto Duties: These Exporters Stand To Gain Big ↗

August 27, 2025

EU set to scrap tariffs on U.S. goods in a key auto trade deal. See which American industrial and energy stocks are poised for a boost.

Via Benzinga

Topics World Trade

HERTHENA-Breast04 Phase 3 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer Previously Treated with Endocrine Therapy

August 27, 2025

From Merck & Co., Inc.

Via Business Wire

Summit Draws Frenzied Retail Chatter After Akeso Drug Shows Survival Benefit In Lung Cancer; Retail Sees More Upside ↗

August 26, 2025

Analysts at Bernstein called the survival data “a positive surprise,” framing it as Akeso’s biggest catalyst since the drug previously outperformed Merck’s top-selling cancer therapy.

Via Stocktwits

As the Market Rotates, This Healthcare ETF Is Leading the Way ↗

August 26, 2025

Health care saw some of the worst losses this year. But as the calendar turned to August, it's been leading the market higher. This ETF provides exposure.

Via MarketBeat

Topics ETFs

Explore the top gainers and losers within the S&P500 index in today's session. ↗

August 25, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Monday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts ↗

August 25, 2025

Powell’s dovish Jackson Hole remarks signal that the Fed could cut rates as early as September, with markets now pricing an 80% chance of a 25 bps cut.

Via MarketBeat

Topics ETFs Economy

HCW Biologics' Shares Surge After Unveiling Next-Gen Cancer Immunotherapy Platform ↗

August 25, 2025

HCW Biologics shares jump after unveiling TRBC-based fusion therapy that enhances immune response and shows strong preclinical results in solid tumors.

Via Benzinga

Merck Demonstrates Ongoing Commitment to Advancing Cardiovascular Disease Management and Patient Care with New Data at the European Society of Cardiology Congress 2025

August 25, 2025

From Merck & Co., Inc.

Via Business Wire

What's going on in today's session: S&P500 movers ↗

August 21, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

Slocum Gordon Exits Stake in Kimberly-Clark Worth Nearly $3 Million ↗

August 21, 2025

Via The Motley Fool

Vets and Pet-Owners See Gaps in Flea and Tick Prevention, Highlighting Need for Year-Round Care, New Merck Animal Health Global Survey Finds

August 19, 2025

From Merck & Co., Inc.

Via Business Wire

Ifinatamab Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Pretreated Extensive-Stage Small Cell Lung Cancer

August 18, 2025

From Daiichi Sankyo

Via Business Wire

2 Value Stocks on Our Watchlist and 1 Facing Challenges

August 18, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

Via StockStory

2 Top Dividend Stocks to Buy on the Dip ↗

August 16, 2025

These blue chip healthcare stocks could still deliver strong long-term returns.

Via The Motley Fool

Topics Earnings Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Merck & Co (NY:MRK)

All News about Merck & Co

Starting at $3.75/week.

Subscribe Today